Genmab | GEN - Interest Expense On Debt

Stock Price
1,832.50
Daily Change
-21.00 -1.13%
Monthly
-13.15%
Yearly
14.67%
Q1 Forecast
1,757.86

Genmab reported DKK37M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Agios Pharmaceuticals USD 1.39B 85.53M Sep/2025
Amarin USD 3K 5K Dec/2024
Amgen USD 653M 32M Dec/2025
argenx SE USD 993K 133K Sep/2025
AstraZeneca USD 484M 181M Dec/2025
Bayer EUR 762M 267M Sep/2025
BioMarin Pharmaceutical USD 2.58M 100K Sep/2025
Demant DKK 398M 37M Dec/2025
Exelixis USD 23.4M 3.9M Sep/2023
Fresenius Medical Care EUR 93.1M 3.48M Sep/2025
Galapagos EUR 1.72M 940K Sep/2025
Genmab DKK 37M 28M Sep/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
GN Store Nord DKK 296M 42M Dec/2025
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 20M 2M Jun/2025
Insmed USD 20.6M 217K Dec/2025
Lonza CHF 84M 14M Jun/2025
Merck EUR 126M 47M Sep/2025
Novartis USD 281M 8M Sep/2025
Regeneron Pharmaceuticals USD 12.2M 7.1M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR -25M 252M Dec/2025
UCB EUR 78M 30M Jun/2025